Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin-18 (TSPAN18) is a member of the tetraspanin superfamily of membrane proteins, characterized by four transmembrane domains. It is expressed at relatively high levels in endothelial cells and regulates the trafficking, surface localization, and clustering of the Ca²⁺ channel Orai1. Through this interaction, TSPAN18 controls store-operated calcium entry and is essential for von Willebrand factor release upon endothelial activation by inflammatory stimuli. Loss or inhibition of TSPAN18 impairs endothelial Ca²⁺ signaling, reduces release of pro-thrombotic mediators, and protects from thrombo-inflammatory diseases in mice models, but also predisposes to increased bleeding. TSPAN18 has potential as a selective therapeutic target for diseases driven by endothelial activation and thrombosis.
Theoretical: inhibition/modulation of TSPAN18 would reduce endothelial Ca²⁺ signaling and von Willebrand factor release, limiting thrombo-inflammatory response. By targeting the interaction with Orai1, selective modulation of store-operated Ca²⁺ entry could be achieved in endothelial cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin-18 (TSPAN18).